Charles River Laboratories International, Inc. (CRL)
222.08
+3.89
(+1.78%)
USD |
NYSE |
Jan 21, 12:42
Charles River Laboratories International Market Cap: 10.93B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 961.70B |
| Johnson & Johnson | 521.95B |
| UnitedHealth Group, Inc. | 312.18B |
| Regeneron Pharmaceuticals, Inc. | 77.85B |
| Moderna, Inc. | 18.50B |
Market Cap Related Metrics
| PS Ratio | 2.770 |
| Price to Book Value | 3.210 |
| Price to Free Cash Flow | 20.50 |
| Price | 222.08 |
| Earnings Yield | -0.70% |
| Operating PE Ratio | 23.20 |
| Normalized PE Ratio | 65.14 |